Pediatric psychopharmacology and the interaction between drugs and the developing brain

Canadian Journal of Psychiatry

Volumn 43, Issue 6, 1998, Pages 582-584

  Vitiello, Benedetto ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain; Development; Psychopharmacology

Indexed keywords

PSYCHOTROPIC AGENT;

BRAIN DEVELOPMENT; CHILD; CHILD DEVELOPMENT; CHILD PSYCHIATRY; DRUG USE; HUMAN; PRESCRIPTION; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0031795682     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379804300605     Document Type: Review

References (21)

1. Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, and others. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialities. JAMA 1998;279:526-31.
2. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. 4th ed. Lear & Febiger: Philadelphia, 1991. p 242-6.
3. Huttenlocher PR. Morphometric study of human cerebral cortex development. Neuropsychologia 1990;28:517-27.
4. Chugani HT, Phelps ME, Mazziotta J, Positron emission tomography study of human brain functional development. Ann Neurol 1997;22:487-97.
5. Seeman P, Bzowej NH, Guan H-C, Bergeron C, Becker LE, Reynolds GP, and others. Human brain dopamine receptors in children and aging adults. Synapse 1987;1:399-404.
6. Borella A, Bindra M, Whitaker-Azmitia PM. Role of the 5-HT1A receptor in development of the neonatal rat brain: preliminary behavioral studies. Neuropharmacology 1997;36:445-50.
7. Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia PM. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 1997;760:68-73.
8. Hill HP, Engblom J. Effects of pre- and postnatal haloperidol administration to pregnant and nursing rats on brain catecholamine levels in their offspring. Developmental Pharmacology and Therapeutics 1984;7:188-97.
9. Rosengarten H, Friedhoff AJ. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science 1979;203:1133-5.
10. Haldelman GE, Quirion R. Neonatal exposure to morphine increases μ-opiate binding in the adult forebrain. Eur J Pharmacol 1983;94:357-8.
11. Armenteros JL, Adams PB, Campbell M, Eisenberg Z. Haloperidol related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol Bull 1995;31:363-9.
12. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall J. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 1997;36:S35-43.
13. Farwell RF, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson JB. Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence. N Engl J Med 1990;322:364-9.
14. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, and others. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 1994;28:336-48.
15. Omtzigt JGC, Los FJ, Grobbee DE, Pijpers L, Jahoda MGJ, Brandenburg H, and others. The risk of spina bifida aperta in first-trimester exposure to valproate in a prenatal cohort. Neurology 1992;42(5 Suppl):119S-25S.
16. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324:674-7.
17. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994;271:146-50.
18. Shou M. What happened to the lithium babies: a follow-up study of children born without malformations. Acta Psychiatrica Scand 1976;54:193-7.
19. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996;153:592-606.
20. Chambers D, Chambers BA, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth ' outcomes in pregnant women taking fluoxetine. N Eng J Med 1996;335:1010-5.
21. Nulman I, Rovet J, Syewart DE, Wolpin J, Gardner HA, Theis JGW, and others. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62.